An innovative deal, an expanding direct secondaries firm, the leading advisor in the region and a law firm that advised on $2.6bn-worth of deals.
There was a 'significant uptick' in financing requests for GP-led deals in the third and fourth quarter, according to a survey by the lender.
The appointment comes as the firm seeks to raise more than $10bn across various funds in its next fundraising cycle.
The listed alternatives giant hired two Partners Groups executives last year to help launch the effort, which could grow to a $50bn business overall for the firm.
Secondaries funds returned net IRR of negative 1.75% in Q2 – the only strategy to go into negative territory – according to the latest data from the industry body.
The appointments come as the investment giant is understood to be seeking as much as $2bn for its debut fund focusing on the strategy.
The secondaries firm expects to match or exceed previous fundraising cycles despite the impact of covid-19, according to the chief executive of parent company BrightSphere.
CEO Kewsong Lee says there was a ‘huge cross sell’ between AlpInvest and the rest of Carlyle, with more than 40% of LPs invested in both.
The number of sponsor-led secondaries coming to market this year is expected to be bolstered by fundraising delays, rising demand in China for US dollar commitments and a backlog of transactions.
The firm is investing its Secondary Fund IV, which closed in November on €1.6bn after 18 months in market.